Molecular diagnosis of respiratory viruses

Pathology

Volumn 47, Issue 3, 2015, Pages 243-249

  Somerville, Lucy K ^a   Mala Ratnamohan, V ^a   Dwyer, Dominic E ^a,b,c   Kok, Jen ^a,b,c  

^a WESTMEAD HOSPITAL   (Australia)

^b University of Sydney   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Diagnostics; molecular; PCR; respiratory viruses

Indexed keywords

HUMAN; MICROBIOLOGICAL EXAMINATION; MOLECULAR DIAGNOSIS; RESPIRATORY TRACT INFECTIONS; VIROLOGY; VIRUS DISEASES;

HUMANS; MICROBIOLOGICAL TECHNIQUES; MOLECULAR DIAGNOSTIC TECHNIQUES; RESPIRATORY TRACT INFECTIONS; VIRUS DISEASES;

EID: 84941259008     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0000000000000240     Document Type: Article

References (86)

1. 1. Centers for Medicare and Medicaid Services. Data Compendium, 2011 Edition. 4 Apr 2013, cited 11 Dec 2014. http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/DataCompendium/2011_Data_Compendium.html.
2. 2. NSW Government, Health Communicable Diseasese. Influenza Monthly Epidemiology Report, December 2013 (including a summary for the year 2013). Dec 2013, cited 31 Oct 2014. http://www.health.nsw.gov.au/Infectious/Influenza/Documents/2013/december-report.pdf.
3. 3. Newall, A.T., Wood, J.G., MacIntyre, C.R., Influenza-related hospitalisation and deaths in Australians aged 50 years and older. Vaccine 26 (2008), 2135–2141.
4. 4. Tillett, H.E., Smith, J.W., Gooch, C.D., Excess deaths attributable to influenza in England and Wales: age at death and certified cause. Int J Epidemiol 12 (1983), 344–352.
5. 5. MacIntyre, C.R., Heywood, A.E., Kovoor, P., et al. Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study. BMJ 99 (2013), 1843–1848.
6. 6. Falsey, A.R., Hennessey, P.A., Formica, M.A., Cox, C., Walsh, E.E., Respiratory syncytial virus infection in the elderly and high-risk adults. N Engl J Med 352 (2005), 1749–1759.
7. 7. Jacobs, S.E., Lamson, D.M., St, George K, Walsh, T.J., Human rhinoviruses. Clin Micobiol Rev 26 (2013), 135–162.
8. 8. Kumar, S., Henrickson, K.J., Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic. Clin Microbiol Rev 25 (2012), 344–361.
9. 9. Franz, A., Adams, O., Willems, R., et al. Correlation of viral load od respiratory pathogens and co-infections with disease severity in children hospitalized for lower respiratory tract infection. J Clin Virol 48 (2010), 239–245.
10. 10. To, K.K., Chan, K.H., Li, I.W., et al. Viral load in patients infected with pandemic H1N1 2009 influenza A virus. J Med Virol 82 (2010), 1–7.
11. 11. Lee, N., Chan, P.K., Hui, D.S., et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 200 (2009), 492–500.
12. 12. Yu, L., Wang, Z., Chen, Y., et al. Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus. Clin Infect Dis 57 (2013), 1449–1457.
13. 13. Lassaunière, R., Kresfelder, T., Venter, M., A novel multiplex real-time RT-PCR assay with FRET hybridization probes for the detection and quantitation of 13 respiratory viruses. J Virol Methods 165 (2010), 254–260.
14. 14. Memish, Z.A., Al-Tawfiq, J.A., Makhdoom, H.Q., et al. Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome. J Infect 210 (2014), 1590–1594.
15. 15. Rhedin, S., Lindstrand, A., Rotzén-Östlund, M., et al. Clinical utility of PCR for common viruses in acute respiratory illness. Pediatrics 133 (2014), e538–e545.
16. 16. Rath, B., von Kleist, M., Tief, F., et al. Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with influenza A(H1N1) 2009 and influenza B viruses. Pediatr Infect Dis J 31 (2012), 899–905.
17. 17. Hayden, F.G., Advances in antivirals for non-influenza respiratory virus infections. Influenza Other Respir Viruses 7:Suppl 3 (2013), 36–43.
18. 18. Tramontana, A.R., George, B., Hurt, A.C., et al. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis 16 (2010), 1068–1075.
19. 19. Hurt, A.C., Ernest, J., Deng, Y.M., et al. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res 83 (2009), 90–93.
20. 20. Hurt, A.C., Chotpitayasunondh, T., Cox, N.J., et al. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis 12 (2012), 240–248.
21. 21. Steain, M.C., Dwyer, D.E., Hurt, A.C., et al. Detection of influenza A H1N1 and H3N2 mutations conferring resistance to oseltamivir directly on clinical specimens using rolling circle amplification. Antiviral Res 84 (2009), 242–248.
22. 22. Deng, Y.M., Caldwell, N., Barr, I.G., Rapid detection and subtyping of human influenza Aviruses and reassortants by pyrosequencing. PLoS One, 6, 2011, e23400.
23. 23. Smith, G.J., Bahl, J., Vijaykrishna, D., et al. Dating the emergence of pandemic influenza viruses. Proc Natl Acad Sci USA 106 (2009), 11709–11712.
24. 24. O'Sullivan, M., Infectious Diseases Informatics, 2010, Springer, New York Chapter 17, Microbial genotyping systems for infection control.
25. 25. Zhou, F., Wang, Q., Sintchenko, V., et al. Use of the 5’ untranslated region and VP1 region to examine the molecular diversity in enterovirus B species. J Med Microbiol 63 (2014), 1339–1355.
26. 26. Wang, B., Taylor, J., Ratnamohan, M., et al. Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza A(H1N1)pdm09 virus, Australia, June to August 2011. Euro Surveill, 17, 2012, 20210.
27. 27. Cheng, A.C., Holmes, M., Kotsimbos, T., et al. Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: A test-negative observational study. PLoS One, 8, 2013, e68760.
28. 28. Holmes, E.C., Ghedin, E., Miller, N., et al. Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol, 3, 2005, e300.
29. 29. Oguma, R., Saito, R., Masaki, H., et al. Molecular characteristics of outbreaks of nosocomial infection with influenza A/H3N2 virus variants. Infect Control Hosp Epidemiol 32 (2011), 267–275.
30. 30. Vijaykrishna, D., Holmes, E.C., Joseph, U., et al. The contrasting phylodynamics of human influenza B viruses. eLife, 4, 2015 (Epub ahead of print).
31. 31. Branche, A.R., Walsh, E.E., Formica, M.A., Falsey, A.R., Detection of respiratory viruses in sputum from adults by use of automated multiplex PCR. J Clin Microbiol 52 (2014), 3590–3596.
32. 32. Blyth, C.C., Iredell, J.R., Dwyer, D.E., Rapid-test sensitivity for novel swine-origin influenza A(H1N1) virus in humans. N Engl J Med, 361, 2009, 2493.
33. 33. Fiore, A.E., Fry, A., Shay, D., et al. Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 60 (2011), 1–24.
34. 34. He, Z., Zhuang, H., Zhao, C., Dong, Q., Peng, G., Dwyer, D.E., Using patient-collected clinical samples and sera to detect and quantify the severe acute respiratory syndrome coronavirus (SARS-CoV). Virol J, 4, 2007, 32.
35. 35. Leung, W.K., To, K.K., Chan, P.K., et al. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology 125 (2003), 1011–1017.
36. 36. Peiris, J.S., Yu, W.C., Leung, C.W., et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363 (2004), 617–619.
37. 37. Waghmare, A., Campbell, A.P., Xie, H., et al. Respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes. Clin Infect Dis 57 (2013), 1731–1741.
38. 38. Ko, S.Y., Jang, J.W., Song, D.J., Lim, C.S., Kim, W.J., Evaluation of the Simplexa Flu A/B and RSV test for the rapid detection of influenza viruses. J Med Virol 85 (2013), 2160–2164.
39. 39. Selvaraju, S.B., Tierney, D., Leber, A.L., et al. Influenza and respiratory syncytial virus detection in clinical specimens without nucleic acid extraction using FOCUS direct disc assay is substantially equivalent to the traditional methods and the FOCUS nucleic acid extraction-dependent RT-PCR assay. Diagn Microbiol Infect Dis 78 (2014), 232–236.
40. 40. Anderson, T.P., Werno, A.M., Barratt, K., Mahagamasekera, P., Murdoch, D.R., Jennings, L.C., Comparison of four multiplex PCR assays for the detection of viral pathogens in respiratory specimens. J Virol Methods 191 (2013), 118–121.
41. 41. Pillet, S., Lardeux, M., Dina, J., et al. Comparative evaluation of six commercialized multiplex PCR kits for the diagnosis of respiratory infections. PLoS One, 8, 2013, e72174.
42. 42. Quan, P., Briese, T., Palacios, G., Lipkin, W.I., Rapid sequence-based diagnosis of viral infection. Antiviral Res 79 (2008), 1–5.
43. 43. Mahony, J.B., Nucleic acid amplification-based diagnosis of respiratory virus infections. Expert Rev Anti Infect Ther 8 (2010), 1273–1292.
44. 44. Szewczuk, E., Thapa, K., Anninos, T., et al. Rapid semi-automated quantitative multiplex tandem PCR (MT-PCR) assays for the differential diagnosis of influenza-like illness. BMC Infect Dis, 10, 2010, 113.
45. 45. Babady, N.E., The FilmArray® respiratory panel: an automated, broadly multiplexed molecular test for the rapid and accurate detection of respiratory pathogens. Expert Rev Mol Diagn 13 (2013), 779–788.
46. 46. Blyth, C.C., Webb, S.A., Kok, J., et al. The impact of bacterial and viral co-infection in severe influenza. Influenza Other Respir Viruses 7 (2013), 168–176.
47. 47. Vallières, E., Renaud, C., Clinical and economical impact of multiplex respiratory virus assays. Diagn Microbiol Infect Dis 76 (2013), 255–261.
48. 48. Kalthoff, D., Beer, M., Hoffmann, B., High resolution melting analysis: rapid and precise characterisation of recombinant influenza A genomes. Virol J, 10, 2013, 284.
49. 49. Varillas, D., Bermejo-Martin, J.F., Almansa, R., et al. A new method for detection of pandemic influenza virus using high resolution melting analysis of the neuraminidase gene. J Virol Methods 17 (2011), 284–286.
50. 50. Tong, S.Y., Dakh, F., Hurt, A.C., et al. Rapid detection of the H275Y oseltamivir resistance mutation in influenza A/H1N1 2009 by single base pair RT-PCR and high-resolution melting. PLoS One, 6, 2011, e21446.
51. 51. Tong, S.Y., Giffard, P.M., Microbiological applications of high-resolution melting analysis. J Clin Microbiol 50 (2012), 3418–3421.
52. 52. Nie, S., Roth, R.B., Stiles, J., et al. Evaluation of Alere i Influenza A and B for rapid detection of influenza viruses A and B. J Clin Microbiol 52 (2014), 3339–3344.
53. TM i Influenza A and B isothermal nucleic acid amplification test. J Clin Virol 61 (2014), 81–86.
54. 54. Bell, J.J., Selvarangan, R., Evaulation of the Alere i Influeza A and B nucleic acid amplification test by the use of respiratory specimens collected in viral transport medium. J Clin Microbiol 2014 (2014), 3992–3995.
55. 55. Mahony, J., Chong, S., Bulir, D., Ruyter, A., Mwawasi, K., Waltho, D., Development of a sensitive loop-mediated isothermal amplification assay that provides specimen-to-result diagnosis of respiratory syncytial virus infection in 30 minutes. J Clin Microbiol 51 (2013), 2696–2701.
56. 56. Song, Q., Zhu, R., Sun, Y., et al. Identification of human metapneumovirus genotypes A and B from clinical specimens by reverse transcription loop-mediated isothermal amplification. J Virol Methods 196 (2014), 133–138.
57. 57. Pyrc, K., Milewska, A., Potempa, J., Development of loop-mediated isothermal amplification assay for detection of human coronavirus-NL63. J Virol Methods 175 (2011), 133–136.
58. 58. Liu, J., Nian, Q.G., Li, J., et al. Development of reverse-transcription loop-mediated isothermal amplification assay for rapid detection of novel avian influenza A (H7N9) virus. BMC Microbiol, 14, 2014, 271.
59. 59. Shirato, K., Yano, T., Senba, S., et al. Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virol J, 11, 2014, 139.
60. TM i Influenza A and B: a novel isothermal nucleic acid amplification assay. Influenza Other Respir Viruses, 2015 (in press).
61. 61. Wu, L.T., Curran, M.D., Ellis, J.S., et al. Nucleic acid dipstick test for molecular diagnosis of pandemic H1N1. J Clin Microbiol 48 (2010), 3608–3613.
62. 62. Dineva, M.D., Candotti, D., Fletcher-Brown, F., Allain, J., Lee, H., Simultaneous visual detection of multiple viral amplicons by dipstick assay. J Clin Microbiol 43 (2005), 4015–4021.
63. 63. Wu, L.T., Thomas, I., Curran, M.D., et al. Duplex molecular assay intended for point-of-care diagnosis of influenza A/B virus infection. J Clin Microbiol 51 (2013), 3031–3038.
64. 64. Lau, L.T., Feng, X.Y., Lam, T.Y., Hui, H.K., Yu, A.C., Development of multiplex nucleic acid sequence-based amplification for detection of human respiratory tract viruses. J Virol 168 (2010), 251–254.
65. 65. Wang, B., Potter, S.J., Lin, Y., et al. Rapid and sensitive detection of severe acute respiratory syndrome coronavirus by rolling circle amplification. J Clin Microbiol 43 (2005), 2339–2344.
66. 66. Wang, B., Dwyer, D.E., Blyth, C.C., et al. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections. Antiviral Res 87 (2010), 16–21.
67. 67. Hofstadler, S.A., Sampath, R., Blyn, L.B., et al. TIGER: the universal biosensor. Int J Mass Spectrom 242 (2005), 23–41.
68. 68. Deyde, V.M., Sampath, R., Gubareva, L., RT-PCR/electrospray ionization mass spectrometry approach in detection and characterisation of influenza viruses. Exp Rev Mol Diagn 11 (2011), 41–52.
69. 69. Liu, J., Lim, S.L., Ruan, Y., et al. SARS transmission pattern in Singapore reassessed by viral sequence variation analysis. PLoS Med, 2, 2005, e43.
70. 70. Ratnamohan, V.M., Taylor, J., Zeng, F., et al. Pandemic clinical case definitions are non-specific: multiple respiratory viruses circulating in the early phases of the 2009 influenza pandemic in New South Wales, Australia. Virol J, 11, 2014, 113.
71. 71. Lynfield, R., Davey, R., Dwyer, D.E., et al. Outcomes of influenza A(H1N1)pdm09 virus infection: results from two international cohort studies. PLoS One, 9, 2014, e101785.
72. 72. Dugas, A.F., Coleman, S., Gaydos, C.A., Rothman, R.E., Frick, K.D., Costutility of rapid polymerase chain reaction-based influenza testing for high-risk emergency department patients. Ann Emerg Med 62 (2013), 80–88.
73. 73. García-García, M.L., Calvo, C., Pozo, F., Villadangos, P.A., Pérex-Breña, P., Casas, I., Spectrum of respiratory viruses in children with community-acquired pneumonia. Pediatr Infect Dis 31 (2012), 808–813.
74. 74. Oosterheert, J.J., van Loom, A.M., Schuurman, R., et al. Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection. Clin Infect Dis 41 (2005), 1438–1444.
75. 75. Blaschke, A.J., Shapiro, D.J., Pavia, A.T., et al. A national study of the impact of rapid influenza testing on clinical care in the emergency department. J Pediatric Infect Dis Soc 3 (2014), 112–118.
76. 76. Corman, V.M., Eckerle, I., Bleicker, T., et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Emerg Infect Dis, 17, 2012, 20285.
77. 77. Agnihothram, S., Gopal, R., Yount, B.L. Jr., et al. Evaluation of serologic and antigenic relationships between Middle Eastern Respiratory Syndrome Coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses. J Infect Dis 209 (2014), 995–1006.
78. 78. Kok, J., Dwyer, D.E., How common was 2009 pandemic influenza A H1N1?. Lancet Infect Dis 11 (2011), 423–424.
79. 79. Playford, E.G., Dwyer, D.E., Laboratory diagnosis of influenza virus infection. Pathology 34 (2002), 115–125.
80. 80. He, Z., Dong, Q., Zhuang, H., Song, S., Peng, G., Guangxiang, L., Dwyer, D.E., Kinetics of severe acute respiratory syndrome (SARS) coronavirus-specific antibodies in 271 laboratory confirmed cases of SARS. Clin Diagn Lab Immunol 11 (2004), 792–794.
81. 81. Kok, J., Tudo, K., Blyth, C.C., Foo, H., Hueston, L., Dwyer, D.E., Pandemic (H1N1) 2009 influenza seroconversion rates in HIV-infected individuals. J Acquir Immune Defic Syndr 56 (2011), 91–94.
82. 82. Iwasenko, J.M., Cretikos, M., Paterson, D.L., et al. Enhanced diagnosis of pandemic (H1N1) 2009 influenza infection using molecular and serological testing in intensive care unit patients with suspected influenza. Clin Infect Dis 51 (2010), 70–72.
83. 83. Trauer, J.M., Bandaranayake, D., Booy, R., et al. Seroepidemiologic effects of influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore. Emerg Infect Dis 19 (2013), 92–101.
84. 84. Kok, J., Dwyer, D.E., The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong: accuracy amidst ambiguity. Clin Infect Dis 53 (2011), 100–101.
85. 85. Kim, H., Oh, S., Yun, K.A., Sung, H., Kim, M., et al. Comparison of Anyplex II RV16 with the xTAG Respiratory Viral Panel and Seeplex RV15 for detection of respiratory viruses. J Clin Microbiol 51 (2013), 1137–1141.
86. 86. Alby, K., Popowitch, E.B., Miller, M.B., Comparative evaluation of the Nanosphere Verigene RV+ assay and the Simplexa Flu A/B & RSV kit for detection of influenza and respiratory syncytial virus. J Clin Microbiol 51 (2012), 352–353.